{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:39:50Z","timestamp":1793353190474,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HONG16A0"],"award-info":[{"award-number":["HONG16A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23-HL146970"],"award-info":[{"award-number":["K23-HL146970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HONG16A0"],"award-info":[{"award-number":["HONG16A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23-HL146970"],"award-info":[{"award-number":["K23-HL146970"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>The clinical significance of Aspergillus fumigatus (Af) detection in the absence of allergic bronchopulmonary aspergillosis in cystic fibrosis (CF) airways remains unclear. Yet, some clinicians initiate antifungal therapy for Af-positive respiratory cultures out of concern for infection in people with CF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the association between the presence of Af and respiratory outcomes in individuals with CF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective longitudinal cohort study of 206 adults and adolescents (age 14 yr and older) with CF and collected sputum for selective fungus culture. We assessed clinical outcome measurements, including patient-reported outcomes (measured by the Cystic Fibrosis Questionnaire\u2013Revised), spirometry, and number of pulmonary exacerbations (PEx) for a 1-year period. We used mixed-effects linear models to determine the association between positive Af culture results, defined as Af detection in sputum culture at the study visit, with both respiratory domain score and forced expiratory volume in 1 second (FEV1) percent predicted, adjusted for confounders. Mixed-effects Poisson regression models were employed to examine the association between positive Af culture results and PEx events. We explored the association between Af history, defined as Af detection at baseline or within 2 years of enrollment, and respiratory outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Af prevalence was 10.3% (95% confidence interval [CI], 6.8, 15.7) at baseline. Forty-eight (23.3%; 95% CI, 17.7, 29.7) participants had at least one Af-positive culture result during the study period. Positive Af culture result was not associated with lower respiratory domain score. However, Af history was associated with a 6.48-point lower respiratory domain score, reflective of worse respiratory quality of life (95% CI, \u221211.96, \u22120.99; P\u2009=\u20090.02). Positive Af culture result was associated with a 2.54% lower FEV1 percent predicted (95% CI, \u22124.64, \u22120.44; P\u2009=\u20090.02) and a 1.71-fold increase in severe PEx incidence (95% CI, 1.05, 2.76; P\u2009=\u20090.03).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Positive Af culture result was not associated with lower patient-reported, respiratory-related quality of life. Yet, positive Af culture result was associated with both lower FEV1 percent predicted and increased frequency of severe PEx warranting intravenous antibiotics in adolescents and adults with CF. Future studies are required to better understand the direct role of Af in lung disease progression in CF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202210-852oc","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T14:05:49Z","timestamp":1676642749000},"page":"984-992","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":18,"title":["The Clinical Association between\n                    <i>Aspergillus fumigatus<\/i>\n                    and Respiratory Outcomes in Adolescents and Adults with Cystic Fibrosis"],"prefix":"10.1093","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3011-0174","authenticated-orcid":false,"given":"Anna L.","family":"O\u2019Dea","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care, Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4151-7228","authenticated-orcid":false,"given":"Rui","family":"Feng","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8463-5107","authenticated-orcid":false,"given":"Laurel J.","family":"Glaser","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kubrak","sequence":"additional","affiliation":[{"name":"Division of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine in Saint Louis, St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3138-4006","authenticated-orcid":false,"given":"Ronald C.","family":"Rubenstein","sequence":"additional","affiliation":[{"name":"Division of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine in Saint Louis, St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3996-9535","authenticated-orcid":false,"given":"Daniel J.","family":"Dorgan","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care, Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8602-9503","authenticated-orcid":false,"given":"Denis","family":"Hadjiliadis","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7896-0608","authenticated-orcid":false,"given":"Steven M.","family":"Kawut","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care, Department of Medicine"},{"name":"Center for Clinical Epidemiology and Biostatistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9321-8399","authenticated-orcid":false,"given":"Gina","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care, Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"key":"2026012203275580100_bib1","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"2026012203275580100_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/thx.2006.060889","article-title":"Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis","volume":"62","author":"Goss","year":"2007","journal-title":"Thorax"},{"key":"2026012203275580100_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13693780802609604","article-title":"Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis\u2014a review","volume":"47","author":"Pihet","year":"2009","journal-title":"Med Mycol"},{"key":"2026012203275580100_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/17460913.1.1.53","article-title":"Cystic fibrosis: a polymicrobial infectious disease","volume":"1","author":"Sibley","year":"2006","journal-title":"Future Microbiol"},{"key":"2026012203275580100_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/CMR.00036-10","article-title":"Clinical significance of microbial infection and adaptation in cystic fibrosis","volume":"24","author":"Hauser","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"2026012203275580100_bib6","volume-title":"Cystic Fibrosis Foundation Patient Registry, 2019 annual data report","author":"Cystic Fibrosis Foundation","year":"2020"},{"key":"2026012203275580100_bib7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1128\/JCM.02182-16","article-title":"Use of selective fungal culture media increases rates of detection of fungi in the respiratory tract of cystic fibrosis patients","volume":"55","author":"Hong","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2026012203275580100_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jcf.2009.11.010","article-title":"Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis","volume":"9","author":"Sudfeld","year":"2010","journal-title":"J Cyst Fibros"},{"key":"2026012203275580100_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201810-1919OC","article-title":"Changing prevalence of lower airway infections in young children with cystic fibrosis","volume":"200","author":"Breuer","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203275580100_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/mmy\/myw035","article-title":"Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center","volume":"54","author":"Ziesing","year":"2016","journal-title":"Med Mycol"},{"key":"2026012203275580100_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s100960050011","article-title":"Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis","volume":"19","author":"Cimon","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026012203275580100_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.09-1103","article-title":"The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis","volume":"137","author":"Amin","year":"2010","journal-title":"Chest"},{"key":"2026012203275580100_bib13","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/ppul.24577","article-title":"Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis","volume":"55","author":"Wagener","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"2026012203275580100_bib14","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s10096-015-2474-y","article-title":"Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship","volume":"34","author":"Noni","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026012203275580100_bib15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1164\/rccm.201203-0478OC","article-title":"The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis","volume":"186","author":"Coughlan","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203275580100_bib16","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ejrad.2011.01.114","article-title":"Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population","volume":"81","author":"McMahon","year":"2012","journal-title":"Eur J Radiol"},{"key":"2026012203275580100_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jcf.2021.07.008","article-title":"Clinician variability in the diagnosis and treatment of Aspergillus fumigatus-related conditions in cystic fibrosis: an international survey","volume":"21","author":"Hong","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2026012203275580100_bib18","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis \u2014 state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2026012203275580100_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcf.2019.08.008","article-title":"The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis","volume":"19","author":"Hong","year":"2020","journal-title":"J Cyst Fibros"},{"key":"2026012203275580100_bib20","first-page":"S302","article-title":"The impact of Aspergillus fumigatus on respiratory-related quality of life in cystic fibrosis [abstract]","volume":"54","author":"Hong","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"2026012203275580100_bib21","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation","volume":"181S","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"key":"2026012203275580100_bib22","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1378\/chest.128.4.2347","article-title":"Development and validation of the Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis","volume":"128","author":"Quittner","year":"2005","journal-title":"Chest"},{"key":"2026012203275580100_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"2026012203275580100_bib24","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update: an official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203275580100_bib25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","article-title":"Standardization of spirometry: 1994 update","volume":"152","author":"American Thoracic Society","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203275580100_bib26","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.08-1190","article-title":"Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire\u2013Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest"},{"key":"2026012203275580100_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/aje\/kws412","article-title":"The table 2 fallacy: presenting and interpreting confounder and modifier coefficients","volume":"177","author":"Westreich","year":"2013","journal-title":"Am J Epidemiol"},{"key":"2026012203275580100_bib28","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jcf.2020.08.015","article-title":"Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: a systematic review","volume":"19","author":"McLeod","year":"2020","journal-title":"J Cyst Fibros"},{"key":"2026012203275580100_bib29","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1378\/chest.08-1421","article-title":"Efficacy and safety of inhaled aztreonam lysine for airway Pseudomonas in cystic fibrosis","volume":"135","author":"Retsch-Bogart","year":"2009","journal-title":"Chest"},{"key":"2026012203275580100_bib30","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"2026012203275580100_bib31","doi-asserted-by":"crossref","first-page":"e36077","DOI":"10.1371\/journal.pone.0036077","article-title":"Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study","volume":"7","author":"Aaron","year":"2012","journal-title":"PLoS One"},{"key":"2026012203275580100_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jcf.2018.12.004","article-title":"Measuring recovery in health-related quality of life during and after pulmonary exacerbations in patients with cystic fibrosis","volume":"18","author":"Flume","year":"2019","journal-title":"J Cyst Fibros"},{"key":"2026012203275580100_bib33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1513\/AnnalsATS.201408-393OC","article-title":"A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis","volume":"12","author":"Habib","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203275580100_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcf.2020.08.006","article-title":"Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment","volume":"20","author":"VanDevanter","year":"2021","journal-title":"J Cyst Fibros"},{"key":"2026012203275580100_bib35","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/thx.2011.161117","article-title":"Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis","volume":"66","author":"de Boer","year":"2011","journal-title":"Thorax"},{"key":"2026012203275580100_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jcf.2021.04.007","article-title":"Clinical characteristics of Pseudomonas and Aspergillus co-infected cystic fibrosis patients: a UK registry study","volume":"21","author":"Hughes","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2026012203275580100_bib37","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1469-0691.2010.03429.x","article-title":"Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?","volume":"17","author":"de Vrankrijker","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2026012203275580100_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/thoraxjnl-2018-211550","article-title":"Aspergillus and progression of lung disease in children with cystic fibrosis","volume":"74","author":"Harun","year":"2019","journal-title":"Thorax"},{"key":"2026012203275580100_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/thx.2007.077784","article-title":"Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis","volume":"63","author":"Gustafsson","year":"2008","journal-title":"Thorax"},{"key":"2026012203275580100_bib40","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ppul.24278","article-title":"Change in lung clearance index with microbiological status in children with cystic fibrosis","volume":"54","author":"Walicka-Serzysko","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"2026012203275580100_bib41","doi-asserted-by":"crossref","first-page":"2002686","DOI":"10.1183\/13993003.02686-2020","article-title":"Longitudinal course of clinical lung clearance index in children with cystic fibrosis","volume":"58","author":"Frauchiger","year":"2021","journal-title":"Eur Respir J"},{"key":"2026012203275580100_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.201106-1027OC","article-title":"Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation","volume":"185","author":"Chaudhary","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203275580100_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jcf.2011.06.006","article-title":"Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium","volume":"10","author":"Reihill","year":"2011","journal-title":"J Cyst Fibros"},{"key":"2026012203275580100_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/cid\/cir399","article-title":"Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis","volume":"53","author":"Gangell","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2026012203275580100_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11046-017-0185-x","article-title":"Fungal and bacterial diversity of airway microbiota in adults with cystic fibrosis: concordance between conventional methods and ultra-deep sequencing, and their practical use in the clinical laboratory","volume":"183","author":"Botterel","year":"2018","journal-title":"Mycopathologia"},{"key":"2026012203275580100_bib46","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.3109\/13693786.2010.511287","article-title":"Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi","volume":"48","author":"Borman","year":"2010","journal-title":"Med Mycol"},{"key":"2026012203275580100_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J Cyst Fibros"},{"key":"2026012203275580100_bib48","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1513\/AnnalsATS.202111-1294OC","article-title":"Clinical outcomes of antipseudomonal versus other antibiotics among children with cystic fibrosis without Pseudomonas aeruginosa","volume":"19","author":"Cogen","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203275580100_bib49","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcf.2018.01.008","article-title":"Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis","volume":"17","author":"Hong","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2026012203275580100_bib50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/20\/7\/984\/66269057\/annalsats_20_7_984.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/20\/7\/984\/66269057\/annalsats_20_7_984.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:29:13Z","timestamp":1769070553000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/20\/7\/984\/8414674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,1]]},"published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202210-852oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"2022-10-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}